Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Osseous Lesions From Metastatic Breast Cancer”

4 trials

Showing 4 of 4 results

Large-scale testing (Phase 3)Ended earlyNCT00372710
What this trial is testing

Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions

Who this might be right for
Breast Cancer With Bone Metastasis
Novartis 30
Large-scale testing (Phase 3)Study completedNCT00375427
What this trial is testing

Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions

Who this might be right for
Breast Cancer With Bone Metastasis
Novartis Pharmaceuticals 430
Not applicableEnded earlyNCT01760941
What this trial is testing

Compassionate Same-Day Evaluation & Delivery of XRT for Bony Metastasis in Hospice Patients

Who this might be right for
Symptomatic Osseous Bone Lesions From Any Malignancy
Virginia Commonwealth University 1
Early research (Phase 1)Study completedNCT00582920
What this trial is testing

Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer

Who this might be right for
Osseous Lesions From Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center 10

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation